# PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction

> **NCT05709626** · PHASE4 · RECRUITING · sponsor: **Kindai University** · enrollment: 2258 (estimated)

## Conditions studied

- ST-segment Elevation Myocardial Infarction (STEMI)

## Interventions

- **DRUG:** No aspirin (Prasugurel monotherapy)
- **DRUG:** 12-month DAPT

## Key facts

- **NCT ID:** NCT05709626
- **Lead sponsor:** Kindai University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-28
- **Primary completion:** 2025-01-04
- **Final completion:** 2028-01-04
- **Target enrollment:** 2258 (ESTIMATED)
- **Last updated:** 2023-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05709626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05709626, "PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05709626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*